Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The inflammatory process plays an important role in the development of cardiovascular complications in patients with obstructive sleep apnea syndrome (OSAS). YKL-40/chitinase 3-like protein 1 is a novel biomarker of systemic inflammation. This study aimed to investigate whether carotid intima-media thickness (CIMT), a useful marker for early atherosclerosis, is associated with serum YKL-40/chitinase 3-like protein 1 levels in patients with normotensive and nondiabetic OSAS.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Turk Kardiyol Dern Ars

Title: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

ISSN: 1016-5169

ISSN (Print): 1016-5169

Publication date (Electronic): Jun 2015

Volume: 43

Issue: 4

Affiliations

[1 ] Department of Cardiology, Erzincan University Faculty of Medicine, Erzincan, Turkey. eftalka@yahoo.com.

[2 ] Department of Pulmonary Diseases, Erzincan University Faculty of Medicine, Erzincan, Turkey.

[3 ] Department of Cardiology, Erzincan University Faculty of Medicine, Erzincan, Turkey.

[4 ] Department of Pulmonary Diseases, Başkent University Faculty of Medicine, Konya, Turkey.

[5 ] Department of Biochemistry, Erzincan University Faculty of Medicine, Erzincan, Turkey.

Article

PubMed ID: 26142786

SO-VID: bd841a5a-d36c-46c2-8458-b1e99698eff4

History

Data availability:

Comments

Comment on this article

Cited by 6

See all cited by